Rhumbline Advisers Sells 13,085 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Rhumbline Advisers reduced its stake in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 26.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 36,305 shares of the company's stock after selling 13,085 shares during the period. Rhumbline Advisers owned about 0.19% of USANA Health Sciences worth $979,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Millennium Management LLC bought a new position in USANA Health Sciences in the 4th quarter valued at approximately $633,000. Pzena Investment Management LLC increased its holdings in shares of USANA Health Sciences by 3.6% during the fourth quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company's stock worth $39,015,000 after buying an additional 37,466 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of USANA Health Sciences by 2.8% in the 4th quarter. Principal Financial Group Inc. now owns 53,603 shares of the company's stock valued at $1,924,000 after acquiring an additional 1,480 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of USANA Health Sciences by 7.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock valued at $27,751,000 after acquiring an additional 55,059 shares in the last quarter. Finally, Norges Bank bought a new stake in USANA Health Sciences during the 4th quarter worth $953,000. 54.25% of the stock is owned by institutional investors.

Insider Activity

In other USANA Health Sciences news, COO Walter Noot sold 6,291 shares of the stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO G Doug Iiekking sold 4,548 shares of the business's stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 12,013 shares of company stock worth $360,149. Company insiders own 0.63% of the company's stock.

USANA Health Sciences Price Performance

NYSE USNA traded up $0.13 during mid-day trading on Friday, reaching $30.57. 291,825 shares of the stock were exchanged, compared to its average volume of 137,939. USANA Health Sciences, Inc. has a one year low of $23.10 and a one year high of $48.85. The stock has a 50 day simple moving average of $28.49 and a 200-day simple moving average of $30.90. The stock has a market cap of $569.14 million, a P/E ratio of 16.79, a P/E/G ratio of 0.97 and a beta of 0.63.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.03. USANA Health Sciences had a net margin of 3.98% and a return on equity of 8.94%. The company had revenue of $249.54 million during the quarter, compared to analyst estimates of $243.08 million. During the same quarter in the previous year, the business posted $0.86 EPS. Sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have issued reports on USNA shares. Wall Street Zen raised USANA Health Sciences from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd. DA Davidson lowered their price objective on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research note on Thursday, February 27th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.